Cargando…

Clinical management of woman with bleeding disorders: A survey among European haemophilia treatment centres

INTRODUCTION: The impact of bleeding for women with bleeding disorders (WBD) is of increasing focus and importance. Despite this, optimal management strategies are unclear and knowledge gaps persist. AIM: To examine practices and define research priorities on diagnosis and management of WBD in Europ...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Galen, Karin P. M., Lavin, Michelle, Skouw‐Rasmussen, Naja, Ivanova, Eva, Mauser‐Bunschoten, Eveline, Punt, Marieke, Romana, Gerychová, Elfvinge, Petra, D'Oiron, Roseline, Abdul‐Kadir, Rezan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497252/ https://www.ncbi.nlm.nih.gov/pubmed/32459044 http://dx.doi.org/10.1111/hae.14043

Ejemplares similares

Managing women‐specific bleeding in inherited bleeding disorders: A multidisciplinary approach
por: Mauser‐Bunschoten, Eveline P., et al.
Publicado: (2020)

International consensus recommendations on the management of people with haemophilia B
por: Hart, Daniel P., et al.
Publicado: (2022)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021)

The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
por: Zotz, Rainer B., et al.
Publicado: (2019)

A qualitative study on the experiences of haemophilia carriers before, during and after pregnancy
por: Punt, Marieke C., et al.
Publicado: (2021)

The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
por: Poon, Man-Chiu, et al.
Publicado: (2023)

The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
por: Meeks, Shannon L., et al.
Publicado: (2019)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2019)

A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen
por: Kennedy, Megan, et al.
Publicado: (2021)

Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors
por: Golestani, Mina, et al.
Publicado: (2014)

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study
por: van Galen, Karin P.M., et al.
Publicado: (2017)

Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
por: Rocino, Angiola, et al.
Publicado: (2017)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
por: Schütte, Lisette M, et al.
Publicado: (2019)

Estimation of transient increases in bleeding risk associated with physical activity in children with haemophilia
por: Broderick, Carolyn R, et al.
Publicado: (2008)

Association of factor expression levels with annual bleeding rate in people with haemophilia B
por: Burke, Tom, et al.
Publicado: (2022)

Hæmophilia
Publicado: (1905)

Hæmophilia
por: Ruggles, S. D.
Publicado: (1902)

Hæmophilia
por: Porter, Charles A.
Publicado: (1900)

Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool
por: Punt, Marieke C., et al.
Publicado: (2019)

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease
por: van der Valk, Paul R., et al.
Publicado: (2019)

Menstrual and obstetrical bleeding in women with inherited platelet receptor defects—A systematic review
por: Punt, Marieke C., et al.
Publicado: (2020)

Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A
por: Schmitt, Christophe, et al.
Publicado: (2022)

Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study
por: Kennedy, Megan, et al.
Publicado: (2022)

Legg on Hæmophilia
Publicado: (1873)

Malarious Hæmophilia
Publicado: (1890)

The Treatment of Haemophilia
por: Biggs, Rosemary
Publicado: (1969)

Living with Haemophilia
por: Laffan, Mike
Publicado: (1995)

Surgery in rare bleeding disorders: the prospective MARACHI study
por: Rousseau, Florence, et al.
Publicado: (2023)

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A
por: Calvez, Thierry, et al.
Publicado: (2018)

P1672: OCCUPATIONAL INTEGRATION OF ADULTS WITH SEVERE HAEMOPHILIA (INTHEMO): A STUDY BASED ON THE FRANCECOAG REGISTRY
por: Nguyen, Ngoc Anh Thu, et al.
Publicado: (2023)

The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients
por: Kjeld, Nadja Gad, et al.
Publicado: (2018)

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients
por: Ljung, Rolf, et al.
Publicado: (2018)

Newborn screening for haemophilia: The views of families and adults living with haemophilia in the UK
por: Boardman, Felicity K., et al.
Publicado: (2019)

Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines
por: Petkovic, Madison J., et al.
Publicado: (2022)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

How to Manage a Patient with Haemophilia and ACS Requiring PCI: A Battle between Bleeding and Thrombosis
por: Theodoropoulos, Konstantinos C., et al.
Publicado: (2021)

Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders
por: Kaczmarek, Radoslaw, et al.
Publicado: (2021)

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
por: Romanová, Gabriela, et al.
Publicado: (2023)

Hæmophilia in Northern Ireland
por: Nelson, M. G., et al.
Publicado: (1959)

Cannot write session to /tmp/vufind_sessions/sess_mlss2m4sfbd6nd06c673srp3jb